Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
107.53
+0.67 (+0.63%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Earnings Scheduled For July 22, 2021
July 22, 2021
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...
Via
Benzinga
Unusual Options Activity Insight: Abbott Laboratories
July 21, 2021
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Wednesday. The stock price moved down to $117.92 following the option alert. Sentiment: BULLISH...
Via
Benzinga
5 Hottest Earnings Charts This Week
July 21, 2021
These 5 companies are the best this week. One of them hasn’t missed in five years and is also trading near 5-year highs.
Via
Talk Markets
Analyzing Abbott Laboratories's Unusual Options Activity
July 19, 2021
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Monday. The stock price moved up to $119.12 following the option alert. Sentiment: BEARISH Option...
Via
Benzinga
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week...
Via
Benzinga
Exposures
Product Safety
The Future of Connected Health Tech is Here
June 21, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Calling All Young People: Give Blood, Change Lives
June 18, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Diabetes Update: New Data Shows How Abbott's Health Tech Helps More People, In More Places
July 16, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Delivering Long-Term Impact: Abbott's 2020 Sustainability Report
July 15, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
5 Stocks to Own for the Surge in Coronavirus Variants
July 14, 2021
Despite easing restrictions, COVID is going to be around a lot longer than many think.
Via
The Motley Fool
Exposures
COVID-19
Understanding Abbott Laboratories's Unusual Options Activity
July 13, 2021
On Tuesday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved down to $118.44. Sentiment: BULLISH Option Type...
Via
Benzinga
46 Firms Going Ex-Dividend, Including Oracle, Accenture And PNC Financial
July 12, 2021
There are several well-known large-cap stocks going ex-dividend this week
Via
Talk Markets
Abbott Lays Off Around 400 Employees As COVID-19 Test Demand Evaporates
July 09, 2021
Abbott Laboratories (NYSE: ABT) has begun laying off hundreds of workers at its diagnostic plants a month after it slashed its earnings forecasts for the remainder of...
Via
Benzinga
Topics
Workforce
Exposures
COVID-19
Layoff
Danaher Stock Rises To Fresh High; Alderon Acquisition Will Expand DNA Portfolio
June 29, 2021
Danaher stock rose June 18 after it said it's buying Aldevron, which makes DNA and mRNA, a component in Covid19 vaccines, for $9.6 billion.
Via
Investor's Business Daily
These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval
June 28, 2021
Some might be surprised to see income-paying stocks among the ARK Invest founder's high-growth picks.
Via
The Motley Fool
What Does The Fed Rate-Hike Plan Do To Dividend Investors?
June 23, 2021
The Fed forecast for two rate hikes by the end of 2023 changed the outlook for income investors. Some high-yield stocks sold off after the announcement, but there are stocks that offer a decent yield...
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Where Abbott Laboratories Stands With Analysts
June 23, 2021
Analysts have provided the following ratings for Abbott Laboratories (NYSE:ABT) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0...
Via
Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
June 23, 2021
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Wednesday. The stock price moved up to $111.16 following the option alert. Sentiment: BULLISH...
Via
Benzinga
Abbott Earns First-of-Its-Kind Recommendation for High School STEM Interns to Receive College Credit
June 23, 2021
SOURCE: Abbott
Via
3BL Media
Return On Capital Employed Overview: Abbott Laboratories
June 18, 2021
Abbott Laboratories (NYSE:ABT) posted Q1 earnings of $2.11 billion, an increase from Q4 of 13.28%. Sales dropped to $10.46 billion, a 2.29% decrease between quarters. Abbott...
Via
Benzinga
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
June 18, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE:...
Via
Benzinga
Revisiting Abbott Labs: Recent Pullback Found Support At The 52-Week Moving Average
June 16, 2021
Abbott saw its stock drop dramatically when the company lowered guidance on June 1. Even after the lowered guidance the growth rates are better than average. The stock found support at its 52-week...
Via
Talk Markets
This Underappreciated Healthcare Stock Is on Sale: Should You Buy?
June 15, 2021
Despite recent struggles, the investment thesis for this company remains strong.
Via
The Motley Fool
Exposures
COVID-19
What Should Investors Make of Abbott's Reduced Full-Year Guidance?
June 12, 2021
The bad news: COVID-19 test volumes are falling. The good news: Abbott has other growth drivers.
Via
The Motley Fool
Exposures
COVID-19
Understanding Abbott Laboratories's Unusual Options Activity
June 11, 2021
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $110.21. Sentiment: BULLISH...
Via
Benzinga
When Men and Machine Team Up to Battle Parkinson's
June 11, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Bonds
Exposures
COVID-19
Debt Markets
"The Tech That I Work on Would Have Saved His Life."
June 10, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
COVID-19
Intellectual Property
Is Abbott Laboratories a Buy on the Dip?
June 09, 2021
The business is growing in all areas, but is it enough to justify the stock's hefty valuation?
Via
The Motley Fool
COVID's "19": The Weight We've Gained
June 09, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.